JPWO2022138842A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2022138842A5 JPWO2022138842A5 JP2022531536A JP2022531536A JPWO2022138842A5 JP WO2022138842 A5 JPWO2022138842 A5 JP WO2022138842A5 JP 2022531536 A JP2022531536 A JP 2022531536A JP 2022531536 A JP2022531536 A JP 2022531536A JP WO2022138842 A5 JPWO2022138842 A5 JP WO2022138842A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- salt
- sodium
- transdermal administration
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022176040A JP2023011818A (ja) | 2020-12-24 | 2022-11-02 | エピナスチン又はその塩と硫黄系抗酸化剤を含有する経皮投与用医薬組成物 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2020215228 | 2020-12-24 | ||
| JP2020215228 | 2020-12-24 | ||
| PCT/JP2021/047943 WO2022138842A1 (ja) | 2020-12-24 | 2021-12-23 | エピナスチン又はその塩と硫黄系抗酸化剤を含有する経皮投与用医薬組成物 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022176040A Division JP2023011818A (ja) | 2020-12-24 | 2022-11-02 | エピナスチン又はその塩と硫黄系抗酸化剤を含有する経皮投与用医薬組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JPWO2022138842A1 JPWO2022138842A1 (https=) | 2022-06-30 |
| JP7171971B1 JP7171971B1 (ja) | 2022-11-15 |
| JPWO2022138842A5 true JPWO2022138842A5 (https=) | 2022-12-05 |
Family
ID=82158746
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022531536A Active JP7171971B1 (ja) | 2020-12-24 | 2021-12-23 | エピナスチン又はその塩と硫黄系抗酸化剤を含有する経皮投与用医薬組成物 |
| JP2022176040A Pending JP2023011818A (ja) | 2020-12-24 | 2022-11-02 | エピナスチン又はその塩と硫黄系抗酸化剤を含有する経皮投与用医薬組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022176040A Pending JP2023011818A (ja) | 2020-12-24 | 2022-11-02 | エピナスチン又はその塩と硫黄系抗酸化剤を含有する経皮投与用医薬組成物 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20240058356A1 (https=) |
| EP (1) | EP4268825A4 (https=) |
| JP (2) | JP7171971B1 (https=) |
| KR (1) | KR20230124625A (https=) |
| CN (1) | CN116744904A (https=) |
| TW (1) | TW202241448A (https=) |
| WO (1) | WO2022138842A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2022138842A1 (ja) * | 2020-12-24 | 2022-06-30 | 参天製薬株式会社 | エピナスチン又はその塩と硫黄系抗酸化剤を含有する経皮投与用医薬組成物 |
| JP7638310B2 (ja) * | 2022-02-28 | 2025-03-03 | 久光製薬株式会社 | ジャー容器用のブテナフィン含有クリーム剤 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ242358A (en) * | 1991-05-10 | 1994-03-25 | Allergan Inc | Use of thiol compounds to inhibit deposits on a contact lens |
| DE19542281C2 (de) * | 1995-11-14 | 1997-12-04 | Boehringer Ingelheim Kg | Verwendung von Epinastin für die Behandlung der Migräne |
| IT1311924B1 (it) * | 1999-04-13 | 2002-03-20 | Nicox Sa | Composti farmaceutici. |
| KR20050092429A (ko) | 2003-01-22 | 2005-09-21 | 니찌방 가부시기가이샤 | 안질환 치료용 경피 흡수형 제제, 그 사용, 및 안질환치료약의 눈의 국소 조직으로의 이행 방법 |
| US20040247686A1 (en) * | 2003-04-04 | 2004-12-09 | Boehringer Ingelheim International Gmbh | Pharmaceutical compositions comprising epinastine for the treatment of skin diseases |
| JP5021155B2 (ja) * | 2003-08-01 | 2012-09-05 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | エピナスチンと１種以上のさらなる抗−ｈ１−ヒスタミン類との組合せを含む皮膚疾患治療用製薬組成物 |
| CN101217948A (zh) * | 2005-07-08 | 2008-07-09 | 千寿制药株式会社 | 包含依匹那丁的透皮吸收眼科制剂 |
| EP1985298A1 (en) * | 2007-04-24 | 2008-10-29 | Azad Pharma AG | Ophtalmic oil-in-water emulsions containing prostaglandins |
| ES2964555T3 (es) * | 2009-08-24 | 2024-04-08 | Stealth Biotherapeutics Inc | Péptido para uso en la prevención o tratamiento de la degeneración macular |
| US20140271812A1 (en) * | 2013-03-14 | 2014-09-18 | Panacea Pharmaceuticals | Treatment for chemotherapy-induced cognitive impairment |
| EP3302426A4 (en) * | 2015-05-29 | 2018-12-05 | Sydnexis, Inc. | D2o stabilized pharmaceutical formulations |
| WO2018203424A1 (ja) * | 2017-05-01 | 2018-11-08 | 参天製薬株式会社 | 点眼剤 |
| JP7458159B2 (ja) * | 2018-09-28 | 2024-03-29 | ロート製薬株式会社 | 眼科組成物 |
| JP2019108320A (ja) * | 2018-10-31 | 2019-07-04 | 参天製薬株式会社 | ソフトコンタクトレンズの変質を抑制する眼科用組成物 |
| JP6736752B2 (ja) * | 2019-12-17 | 2020-08-05 | 参天製薬株式会社 | エピナスチン含有点眼液 |
| WO2022138842A1 (ja) * | 2020-12-24 | 2022-06-30 | 参天製薬株式会社 | エピナスチン又はその塩と硫黄系抗酸化剤を含有する経皮投与用医薬組成物 |
-
2021
- 2021-12-23 WO PCT/JP2021/047943 patent/WO2022138842A1/ja not_active Ceased
- 2021-12-23 EP EP21910981.6A patent/EP4268825A4/en active Pending
- 2021-12-23 KR KR1020237024027A patent/KR20230124625A/ko active Pending
- 2021-12-23 TW TW110148511A patent/TW202241448A/zh unknown
- 2021-12-23 US US18/269,452 patent/US20240058356A1/en active Pending
- 2021-12-23 CN CN202180084690.1A patent/CN116744904A/zh active Pending
- 2021-12-23 JP JP2022531536A patent/JP7171971B1/ja active Active
-
2022
- 2022-11-02 JP JP2022176040A patent/JP2023011818A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPWO2022138842A5 (https=) | ||
| KR101904850B1 (ko) | 마이봄선을 표적화하는 영양 보충물 | |
| Law | Bimatoprost in the treatment of eyelash hypotrichosis | |
| CN102355889B (zh) | 基于多不饱和ω-3和ω-6脂肪酸的眼用组合物 | |
| US7550508B2 (en) | Prostaglandin analog compositions and methods to treat epithelial-related conditions | |
| ES2686295T3 (es) | N-Acetil-DL-leucina, medicamento neuroprotector y retinoprotector | |
| RU2010121989A (ru) | Композиция для местного введения | |
| US11484516B2 (en) | Agents for increasing meibomian gland lipid secretion | |
| JP2018514592A5 (https=) | ||
| JP2020505385A (ja) | 神経変性疾患及び／又は自己免疫性疾患の処置において使用するための抗炎症性脂質メディエーター | |
| Zhou et al. | The molecular mechanisms of action of PPAR-γ agonists in the treatment of corneal alkali burns | |
| US9629847B2 (en) | Compositions and methods for treating symptoms of inflammatory related conditions using a combination of an antihistamine and a stimulant | |
| US2431558A (en) | Vasodilator compositions comprising alkyl nicotinates | |
| US20250360076A1 (en) | Compositions containing plant mucilage | |
| RU2726978C2 (ru) | Сочетание липоевой кислоты и таурина в качестве осмопротекторного агента | |
| JPWO2022138826A5 (https=) | ||
| WO2008057364A1 (en) | Method for treating blepharitis | |
| US9149474B2 (en) | Compositions and methods for treating symptoms of inflammatory related conditions using a combination of an antihistamine and a stimulant | |
| Patel et al. | Diseases of the eyelashes | |
| JP2022136242A5 (https=) | ||
| JP6534958B2 (ja) | 消臭化粧料 | |
| JP2022042358A (ja) | コルチゾール合成酵素１１β－ヒドロキシステロイドデヒドロゲナーゼ１活性阻害剤 | |
| Samusiova | PUFA in cosmetic and medicinal creams | |
| BR102023025227A2 (pt) | Processo para obtenção de oleato de etila e usos do mesmo | |
| Shafy | Bulky Tip and Bulky Alar Base |